Muscarinic receptor subtypes in neuronal and non‐neuronal cholinergic function
- 19 June 2006
- journal article
- review article
- Published by Wiley in Autonomic & Autacoid Pharmacology
- Vol. 26 (3), 219-233
- https://doi.org/10.1111/j.1474-8673.2006.00368.x
Abstract
1 Muscarinic M1-M5 receptors mediate the metabotropic actions of acetylcholine in the nervous system. A growing body of data indicate they also mediate autocrine functions of the molecule. The availability of novel and selective muscarinic agonists and antagonists, as well as in vivo gene disruption techniques, has clarified the roles of muscarinic receptors in mediating both functions of acetylcholine. 2 Selective M1 agonists or mixed M1 agonists/M2 antagonists may provide an approach to the treatment of cognitive disorders, while M3 antagonism, or mixed M2/M3 antagonists, are approved for the treatment of contractility disorders including overactive bladder and chronic obstructive pulmonary disease. Preclinical data suggest that selective agonism of the M4 receptor will provide novel anti-nociceptive agents, while therapeutics-based upon agonism or antagonism of the muscarinic M5 receptor have yet to be reported. 3 The autocrine functions of muscarinic receptors broadly fall into two areas - control of cell growth or proliferation and mediation of the release of chemical mediators from epithelial cells, ultimately causing muscle relaxation. The former particularly are involved in embryological development, oncogenesis, keratinocyte function and immune responsiveness. The latter regulate contractility of smooth muscle in the vasculature, airways and urinary bladder. 4 Most attention has focused on muscarinic M1 or M3 receptors which mediate lymphocyte immunoresponsiveness, cell migration and release of smooth muscle relaxant factors. Muscarinic M4 receptors are implicated in the regulation of keratinocyte adhesion and M2 receptors in stem cell proliferation and development. Little data are available concerning the M5 receptor, partly due to the difficulties in defining the subtype pharmacologically. 5 The autocrine functions of acetylcholine, like those in the nervous system, involve activation of several muscarinic receptor subtypes. Consequently, the role of these subtypes in autocrine, as well neuronal cholinergic systems, significantly expands their importance in physiology and pathophysiology.Keywords
This publication has 99 references indexed in Scilit:
- Novel signaling pathways mediating reciprocal control of keratinocyte migration and wound epithelialization through M3 and M4 muscarinic receptorsThe Journal of cell biology, 2004
- Decreased Amphetamine-Induced Locomotion and Improved Latent Inhibition in Mice Mutant for the M5 Muscarinic Receptor Gene Found in the Human 15q Schizophrenia RegionNeuropsychopharmacology, 2004
- Functional M3 muscarinic acetylcholine receptors in mammalian heartsBritish Journal of Pharmacology, 2004
- G-protein–gated TRP-like Cationic Channel Activated by Muscarinic ReceptorsThe Journal of general physiology, 2004
- The C-terminal Tail of the M3-muscarinic Receptor Possesses Anti-apoptotic PropertiesPublished by Elsevier BV ,2003
- Role of the non-neuronal cholinergic system in the eye: A reviewLife Sciences, 2003
- Cholinergic Stimulation of Human Microcitoma Cell Line H69Biochemical and Biophysical Research Communications, 1997
- Activation of Muscarinic Receptors Inhibits Apoptosis in PC12M1 CellsJournal of Neurochemistry, 1995
- In vitro and in vivo modulation of cholinergic muscarinic receptors in rat lymphocytes and brain by cholinergic agentsInternational Journal of Immunopharmacology, 1990
- Cholinergic muscarinic binding by rat lymphocytes: Effects of antagonist treatment, strain and agingBrain Research, 1986